Claudia Ibarra
Net Worth

Last updated:

What is Claudia Ibarra net worth?

The estimated net worth of Ms. Claudia Ibarra is at least $2,477,215 as of 11 Dec 2023. She has earned $725,265 from insider trading and has received compensation worth at least $1,751,950 in DermTech, Inc..

What is the salary of Claudia Ibarra?

Ms. Claudia Ibarra salary is $350,390 per year as Chief Operating Officer in DermTech, Inc..

How old is Claudia Ibarra?

Ms. Claudia Ibarra is 63 years old, born in 1962.

What stocks does Claudia Ibarra currently own?

As insider, Ms. Claudia Ibarra owns shares in one company:

Company Title Shares Price per share Total value
DermTech, Inc. (DMTK) Chief Operating Officer 193,547 $0 $0

What does DermTech, Inc. do?

DermTech, Inc., a molecular diagnostic company, develops and markets novel non-invasive genomics tests to diagnosis skin cancer, inflammatory diseases, and aging-related conditions in the United States. It offers DermTech Melanoma Test (DMT), a gene expression test that enhances early detection of genomic atypia and helps rule out melanoma and the need for a surgical biopsy of atypical pigmented lesions. The company also provides adhesive skin sample collection kits, as well as gene expression assays for the Th1, Th2, IFN-gamma, and Th17 inflammatory pathways. In addition, it is developing UV damage DNA risk assessment products, as well as non-melanoma skin cancer diagnostic and cutaneous T-cell lymphoma rule out test products, as well as offering health-related and information services through electronic information and telecommunication technologies. The company sells its products primarily to pathology and oncology practitioners. DermTech, Inc. is headquartered in La Jolla, California.

DMTK logo
DMTK
DermTech, Inc.

Claudia Ibarra insider trading

DermTech, Inc.

Ms. Claudia Ibarra has made 41 insider trades between 2020-2023, according to the Form 4 filled with the SEC. Most recently she sold 331 units of DMTK stock worth $480 on 11 Dec 2023.

The largest trade she's ever made was exercising 7,605 units of DMTK stock on 10 Sep 2020. As of 11 Dec 2023 she still owns at least 193,547 units of DMTK stock.

Transaction Date Security Shares Price per share Total value Source
Sale
Common Stock 331 $1.45 $480
Sale
Common Stock 2,607 $1.41 $3,676
Sale
Common Stock 143 $1.53 $219
Sale
Common Stock 2,000 $1.53 $3,060
Sale
Common Stock 1,768 $1.53 $2,705
Sale
Common Stock 322 $1.89 $609
Sale
Common Stock 168 $1.93 $324
Sale
Common Stock 2,405 $1.93 $4,642
Sale
Common Stock 2,679 $1.93 $5,170
Sale
Common Stock 2,126 $1.93 $4,103
Sale
Common Stock 322 $2.85 $918
Sale
Common Stock 2,371 $2.61 $6,188
Sale
Common Stock 1,772 $2.53 $4,483
Sale
Common Stock 140 $2.53 $354
Sale
Common Stock 2,004 $2.53 $5,070
Sale
Common Stock 378 $3.26 $1,232
Sale
Common Stock 2,525 $3.88 $9,797
Sale
Common Stock 148 $4.06 $601
Sale
Common Stock 6,943 $4.06 $28,189
Sale
Common Stock 328 $2.22 $728
Sale
Common Stock 2,496 $2.32 $5,791
Sale
Common Stock 137 $2.44 $334
Sale
Common Stock 322 $5.99 $1,929
Sale
Common Stock 2,449 $5.65 $13,837
Sale
Common Stock 133 $5.43 $722
Sale
Common Stock 345 $4.81 $1,659
Sale
Common Stock 2,439 $6.26 $15,268
Sale
Common Stock 133 $6.48 $862
Sale
Common Stock 320 $14.55 $4,656
Sale
Common Stock 2,401 $12.64 $30,349
Sale
Common Stock 623 $13.03 $8,118
Sale
Common Stock 473 $16.71 $7,904
Sale
Common Stock 3,450 $18.46 $63,687
Sale
Common Stock 457 $36.19 $16,539
Sale
Common Stock 3,020 $36.18 $109,264
Sale
Common Stock 1,283 $41.08 $52,709
Sale
Common Stock 2,405 $43.43 $104,449
Sale
Common Stock 2,431 $50.04 $121,647
Sale
Common Stock 2,421 N/A N/A
Sale
Common Stock 7,605 $10.91 $82,993
Sale
Common Stock 7,605 N/A N/A

DermTech key executives

DermTech, Inc. executives and other stock owners filed with the SEC:

  • Dr. John D. Dobak (59) Pres, Chief Executive Officer & Director
  • Mr. Kevin Sun M.B.A. (47) Chief Financial Officer, Treasurer & Sec.
  • Ms. Claudia Ibarra (63) Chief Operating Officer